MGI Tech

MGI Tech has developed robust, high-throughput automated liquid handlers specifically optimized to feed its massive fleets of domestic gene sequencers.

Country: China
Ticker: SSE:688114

Coverage

	CN	EU	US
automation-robotics	✓	✓	✓
bioinformatics-omics	✓	✓	✓
monitoring-conservation	✓	✓	✓

Regulatorsusda-aphismoa-chinaefsafdaemanmpa

Verifiable facts

Fact	Value	Source
Funding	$200+ million Series A in 2019; $1 billion Series B in 2020	medbot.cn · atlantis-press.com
Founded	2016	en.genomics.cn · medbot.cn
Headquarters	Shenzhen, China	medbot.cn · novapharmanews.com · 9fzt.com
Production site	7 production bases worldwide, including sites in Qingdao, Latvia, and the United States	mgi-tech.eu · novapharmanews.com · 9fzt.com
Capacity	2,000 liters of biological enzymes annually at Qingdao base medium confidence	subsites.chinadaily.com.cn
Certification	ISO 13485, ISO 14001, and ISO 27001	medbot.cn · mgi-tech.eu · novapharmanews.com
Regulatory approval	NMPA Class III medical device approval for ultrasound robotics and numerous DNBSEQ sequencing platform models; CE certification for select products	money.finance.sina.com.cn · medbot.cn · vcbeathealth.com
Headcount	Approximately 2,600 employees globally as of 2024	medbot.cn · novapharmanews.com · genomeweb.com
Revenue	RMB 3.01 billion ($414.0 million) in 2024	genomeweb.com

Independent sources: 9fzt.com · atlantis-press.com · en.genomics.cn · genomeweb.com · medbot.cn · money.finance.sina.com.cn · novapharmanews.com · subsites.chinadaily.com.cn · vcbeathealth.com

Technologies

Name	Cluster	Risk
Bioinformatics & multi-omics	bioinformatics-omics	Low	→
Lab automation & liquid handling	automation-robotics	Low	→
Lab automation & wet-lab robotics	automation-robotics	Low	→
Sovereign genome databases (plants, animals, microbes)	monitoring-conservation	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.